Clinical trial

Alfapump Direct Sodium Removal (DSR) Feasibility Study

NCT04116034

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-12-26

PhaseNA

Study timeline

Study start (actual)2019-12-26Date precision: day

Registry last updated2021-05-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureverified · MONDO: heart failure

Congestive Heart Failureverified · MONDO: congestive heart failure

Cardiorenal Syndromeverified · MONDO: cardio-renal syndrome

Volume Overloadunresolved

Sodium Excessunresolved

Sodium Disorderunresolved

Interventions

alfapump DSR systemDEVICE

Sponsors & collaborators

Sequana Medical N.V.lead sponsor

Yale Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04116034 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.